Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago.
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
SI-BONE, Inc. (SIBN) Q4 2025 Earnings Call Transcript
Earnings Preview: Si-Bone (SIBN) Q4 Earnings Expected to Decline
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Si-Bone (SIBN) After Golden Cross?
After reaching an important support level, SiBone (SIBN) could be a good stock pick from a technical perspective. SIBN recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
SI-BONE, Inc. (SIBN) Q3 2025 Earnings Call Transcript
SI-BONE, Inc. ( SIBN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Saqib Iqbal - Director of FP&A and Investor Relations Laura Francis - CEO & Director Anshul Maheshwari - Chief Financial Officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Gracia Mahoney - BofA Securities, Research Division Young Li - Jefferies LLC, Research Division Ross Osborn - Cantor Fitzgerald & Co., Research Division David Saxon - Needham & Company, LLC, Research Division Ravi Misra - Truist Securities, Inc., Research Division Presentation Operator Good afternoon, and welcome to SI-BONE's Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes.
Si-Bone (SIBN) Reports Q3 Loss, Beats Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.16 per share a year ago.
SI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
SI-BONE, Inc. (NASDAQ:SIBN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT Company Participants Laura Francis - CEO & Director Anshul Maheshwari - Chief Financial Officer Presentation Unknown Analyst All right. Good morning.
SI-BONE, Inc. (SIBN) Q2 2025 Earnings Call Transcript
SI-BONE, Inc. (NASDAQ:SIBN ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Anshul Maheshwari - Chief Financial Officer Laura A. Francis - CEO & Director Saqib Iqbal - Director of FP&A and Investor Relations Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Craig William Bijou - BofA Securities, Research Division David Joshua Saxon - Needham & Company, LLC, Research Division David Louis Turkaly - Citizens JMP Securities, LLC, Research Division Felipe Raul Lamar - Truist Securities, Inc., Research Division Junwoo Park - Cantor Fitzgerald & Co., Research Division Matthew Oliver O'Brien - Piper Sandler & Co., Research Division Xuyang Li - Jefferies LLC, Research Division Operator Good afternoon, and welcome to SI-BONE Second Quarter 2025 Earnings Conference Call.
Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.22 per share a year ago.
All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy
Si-Bone (SIBN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 34.2% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now?
Does Si-Bone (SIBN) have what it takes to be a top stock pick for momentum investors? Let's find out.
